Skip to content
Search

Latest Stories

RPS England responds to NHS stocktake review of primary care

In responses to the NHS ‘Fuller Stocktake review’, the Royal Pharmaceutical Society (RPS) has highlighted how pharmacy can support people at the interfaces between primary and secondary care as well as primary health and social care.

The NHS ‘Fuller Stocktake’ review has been looking at how primary care can help meet the health needs of local populations, working within new Integrated Care Systems and alongside wider NHS reforms.


RPS England chair Thorrun Govind said: “This wide-ranging review highlights how collaboration across care settings will be central to the future of health and care in England. Pharmacy teams working in primary care will be central to enhancing patient access to care and supporting the NHS recovery.

“We know that pharmacy teams are ideally placed to engage with local communities and must be at the heart of future efforts to reduce health inequalities. Pharmacists will play a key role supporting medicines optimisation to improve people’s health and also deliver better value for taxpayers.

“This must be supported by governance and leadership of the new Integrated Care Systems and backed up by investment in England in pharmacy education.

“I would urge the NHS and Government to listen to everyone working across the health service with new ideas and who want to help make a difference. I want thank our expert advisory groups and everyone who joined our member webinars to help shape this important piece of work.

“But the conversation does not stop here and we will keep engaging with the NHS and Government on what the Fuller Review means for pharmacy teams and how we can improve outcomes for patients.”

The review is looking at a range of issues in England, including:

  • Workforce, including leadership and education
  • Collection and use of data and information
  • Working with communities and how best to engage with them
  • Physical access to care
  • Non-physical access to care including use of technology and remote consultations
  • Governance and decision making which includes local contracting

Key issues in the RPS submission include:

  • Supporting primary care and understanding the potential of primary care pharmacy to enhance local population health.
  • Governance in new NHS structures and including pharmacy teams in decision-making across medicines, workforce and commissioning.
  • Workforce modelling, professional development and ensuring a pipeline of pharmacists, pharmacy technicians and support staff.
  • Expanding neighbourhood primary care provider collaboratives and multidisciplinary working.
  • Proving seamless care for patients across the health service.
  • Digital infrastructure and supporting innovative areas of practice such as pharmacogenomics and personalised medicines.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less